Shawn M Aarde1, Michelle L Miller1, Kevin M Creehan1, Sophia A Vandewater1, Michael A Taffe2. 1. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, SP30-2400, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. 2. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, SP30-2400, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: mtaffe@scripps.edu.
Abstract
BACKGROUND: Exercise influences drug craving and consumption in humans and drug self-administration in laboratory animals, but the effects can be variable. Improved understanding of how exercise affects drug intake or craving would enhance applications of exercise programs to human drug users attempting cessation. METHODS: Rats were trained in the intravenous self-administration (IVSA) of D-methamphetamine (METH; 0.05 mg/kg/inf), 3,4-methylenedioxymethamphetamine (MDMA; 0.5 mg/kg/inf) or methylone (0.5 mg/kg/inf). Once IVSA was established, the effect of ∼ 22 h of wheel access in the home cage on subsequent drug taking was assessed in a two cohort crossover design. RESULTS: Provision of home cage wheel access during the day prior to IVSA sessions significantly decreased the self-administration of METH, MDMA and methylone. At the individual level, there was no correlation between the amount a rat used the wheel and the size of the individual's decrease in drug intake. CONCLUSIONS: Wheel access can reduce self-administration of a variety of psychomotor stimulants. It does so immediately, i.e., without a need for weeks of exercise prior to drug access. This study therefore indicates that future mechanistic investigations should focus on acute effects of exercise. In sum, the results predict that exercise programs can be used to decrease stimulant drug use in individuals even with no exercise history and an established drug taking pattern.
BACKGROUND: Exercise influences drug craving and consumption in humans and drug self-administration in laboratory animals, but the effects can be variable. Improved understanding of how exercise affects drug intake or craving would enhance applications of exercise programs to human drug users attempting cessation. METHODS:Rats were trained in the intravenous self-administration (IVSA) of D-methamphetamine (METH; 0.05 mg/kg/inf), 3,4-methylenedioxymethamphetamine (MDMA; 0.5 mg/kg/inf) or methylone (0.5 mg/kg/inf). Once IVSA was established, the effect of ∼ 22 h of wheel access in the home cage on subsequent drug taking was assessed in a two cohort crossover design. RESULTS: Provision of home cage wheel access during the day prior to IVSA sessions significantly decreased the self-administration of METH, MDMA and methylone. At the individual level, there was no correlation between the amount a rat used the wheel and the size of the individual's decrease in drug intake. CONCLUSIONS: Wheel access can reduce self-administration of a variety of psychomotor stimulants. It does so immediately, i.e., without a need for weeks of exercise prior to drug access. This study therefore indicates that future mechanistic investigations should focus on acute effects of exercise. In sum, the results predict that exercise programs can be used to decrease stimulant drug use in individuals even with no exercise history and an established drug taking pattern.
Authors: Alexander J Engelmann; Mark B Aparicio; Airee Kim; Jeffery C Sobieraj; Clara J Yuan; Yanabel Grant; Chitra D Mandyam Journal: Brain Struct Funct Date: 2013-02-27 Impact factor: 3.270
Authors: Susan Schenk; Lincoln Hely; Barbara Lake; Evangelene Daniela; David Gittings; Deborah C Mash Journal: Eur J Neurosci Date: 2007-11-14 Impact factor: 3.386
Authors: Kristin M Alvers; Julie A Marusich; Cassandra D Gipson; Joshua S Beckmann; Michael T Bardo Journal: Behav Pharmacol Date: 2012-10 Impact factor: 2.293
Authors: Lucas R Watterson; Lauren Hood; Kaveish Sewalia; Seven E Tomek; Stephanie Yahn; Craig Trevor Johnson; Scott Wegner; Bruce E Blough; Julie A Marusich; M Foster Olive Journal: J Addict Res Ther Date: 2012-12-01
Authors: Jacques D Nguyen; Shawn M Aarde; Maury Cole; Sophia A Vandewater; Yanabel Grant; Michael A Taffe Journal: Neuropsychopharmacology Date: 2016-06-09 Impact factor: 7.853
Authors: Mark A Smith; Gaylen E Fronk; Huailin Zhang; Charlotte P Magee; Andrea M Robinson Journal: Pharmacol Biochem Behav Date: 2016-10-05 Impact factor: 3.533
Authors: C Juarez-Portilla; R D Kim; M Robotham; M Tariq; M Pitter; J LeSauter; R Silver Journal: Psychopharmacology (Berl) Date: 2016-12-27 Impact factor: 4.530
Authors: Mehrak Javadi-Paydar; Eric L Harvey; Yanabel Grant; Sophia A Vandewater; Kevin M Creehan; Jacques D Nguyen; Tobin J Dickerson; Michael A Taffe Journal: Psychopharmacology (Berl) Date: 2018-06-16 Impact factor: 4.530
Authors: Mehrak Javadi-Paydar; Jacques D Nguyen; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe Journal: Neuropharmacology Date: 2017-09-04 Impact factor: 5.250